Doctor profile · Federal record

Dr. Chanda Copeland, Nurse Practitioner

Family Nurse Practitioner (CMS: Nurse Practitioner) · Family Nurse Practitioner · Washington, DC

  • NPI 1477820769
  • Accepts Medicare
  • MIPS 87.7 / 100 · 2023
  • 16 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1500 Galen St Se
Washington, DC 200204936
(202) 610-7160
fax (202) 610-7164
Mailing address
1220 12Th St Se, Suite 120
Washington, DC 200033722

Credentials & registration

NPPES · NUCC
NPI registered
November 2011 — 15 yrs on file
Profile last updated
June 28, 2012
Year of graduation
2010 — 16 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State licenses (2)
District of Columbia #RN65807 · Maryland #R136290
Medicaid
DC #024905300

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1477820769. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,254
Distinct HCPCS
10
Medicare allowed
$88,450
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 251 148 $119
99213 Established patient office or other outpatient visit, 20-29 minutes 237 159 $83
17003 Destruction of precancer skin growth, 2-14 growths 191 32 $6
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 125 48 $1
17110 Destruction of skin growth, 1-14 growths 108 71 $106
11901 Injection into skin growth, more than 7 growths 86 30 $63
17000 Destruction of precancer skin growth, 1 growth 76 49 $49
99203 New patient office or other outpatient visit, 30-44 minutes 41 41 $103
11102 Biopsy of related skin growth, first growth 37 35 $84
11900 Injection into skin growth, 1-7 growths 33 19 $52

In context: peer comparison

Among 92 peers in this city , average services per provider: 75. This provider delivers 17× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,610
Transactions
69
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 17 $396.76
Novartis Pharmaceuticals Corporation 14 $317.48
UCB, Inc. 6 $160.15
PFIZER INC. 8 $155.19
Janssen Biotech, Inc. 3 $90.21
Arcutis Biotherapeutics, Inc. 5 $78.98
LEO Pharma Inc. 3 $78.57
Incyte Corporation 3 $76.58
GENZYME CORPORATION 2 $70.39
Lilly USA, LLC 2 $39.67
E.R. Squibb & Sons, L.L.C. 2 $37.22
Dermavant Sciences, Inc. 1 $33.05
Regeneron Healthcare Solutions, Inc. 1 $31.01
Ortho Dermatologics, a division of Bausch Health US, LLC 1 $22.94
Galderma Laboratories, L.P. 1 $21.77

By nature of payment

Food and Beverage
$1,610

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
306
Patients
140
Total drug cost
$299,339
Drug Type Claims Patients Total cost
Ketoconazole Generic 60 34 $961
Clindamycin Phosphate Generic 46 18 $1,593
Betamethasone Dipropionate Generic 36 16 $2,027
Mometasone Furoate Generic 36 27 $489
Triamcinolone Acetonide Generic 32 22 $828
Ciclopirox Generic 20 12 $629
Fluocinonide Generic 16 11 $906
Humira Pen (Adalimumab) Brand 14 0 $192,476
Cosentyx Sensoready (2 Pens) (Secukinumab) Brand 13 0 $98,161
Clobetasol Propionate Generic 11 0 $445

Frequently asked questions

Auto-generated from federal data
What is Dr. Chanda Copeland's medical specialty?
Dr. Chanda Copeland practices Family Nurse Practitioner in Washington, DC.
Where does Dr. Chanda Copeland practice?
Dr. Chanda Copeland practices at 1500 Galen St Se, Washington, DC 200204936. Office phone: 2026107160.
What is Dr. Chanda Copeland's NPI?
Dr. Chanda Copeland's National Provider Identifier (NPI) is 1477820769, issued by NPPES.
Does Dr. Chanda Copeland accept Medicare assignment?
Yes. Dr. Chanda Copeland accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Chanda Copeland commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.